Understanding Pre-Myeloma (MGUS)
Share This Video
Take Our SurveyA pre-myeloma condition known as MGUS (Monoclonal gammopathy of undetermined significance) isn't cancer, lacking the tell-tale symptoms of the mature disease. Dr. Berenson helps us understand the significance of MGUS and explains the treatment options available.
Health Topics: Monoclonal gammopathy of undetermined significance (MGUS)
Get Email Updates:
Get updated automatically when new content about Monoclonal gammopathy of undetermined significance (MGUS) has been posted.
Privacy Policy
Privacy Policy
Monoclonal gammopathy of undetermined significance (MGUS)
Experts & Guests
|
James Berenson, M.D.
Founder, President and Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research
James Berenson, M.D. is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research. Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 25 years. He has been involved in many of the major breakthroughs that have brought new treatments for...
more >
|
|
|
